ORII, T., YAMAGUCHI, M., MINAMI, R. and NAKAO, T. Decrease of Urinary Acid Mueopolysaccharides in Hurler's Syndrome after Plasma Infusion. Tohoku J. exp. Med., 1974, 112 (4) , 385-387 -The fresh plasma infusion in patients affected by Hurler, Scheie or Morquio syndromes was followed by a decreased urinary excretion of chondroitin sulfate B or keratosulfate.
Furthermore, in all of the patients the infusion was followed by an increased excretion of the non cetylpyridinium chloride precipitates. mucopolysaccharidosis; plasma infu sion Recently, DiFerrante et al. (1971) reported that plasma infusion in Hurler and Hunter syndromes was followed by a decreased urinary excretion of acid mucopolysaccharides (AMPS) and by an increased excretion of their products.
After a time, however, no or little alteration of the total urinary excretion of AMPS by plasma infusion was indicated by several workers (Dekaban et al. 1972; Erickson et al. 1972; Danes et al. 1973) .
Urine before, during, and after plasma infusion was collected from four patients: two cases with Hurler syndrome, one case with Scheie syndrome and one case with Morquio syndrome.
Compatible fresh human plasma was infused intravenously and each patient received a total of 1,200 ml of plasma in a 30 hr period continuously.
Urinary cetylpyri dinium chloride (CPC)-precipitates (AMPS) and non-CPC-precipitates from the patients before, during, and after plasma infusion were isolated as described by DiFerrante (1967) and Orii et al. (1972b) .
Testicular hyaluronidase and chondroitinase ABC digestions were carried out by method of Saito et al. (1968) . Colorimetric determinations of uronic acid, hexosamine and creatinine have been described previously (Orii et al. 1972a ).
As shown in Fig. 1 , on the third day of the infusion, the excretion of AMPS decreased most sharply in Cases 2, 3 and 4. However, in Case 1, it decreased on the fourth day. In Cases 1, 2 and 4, the excretion of non-CPC-precipitates increased most sharply on the fourth day. In Case 3, however, it increased most sharply on the sixth day. Furthermore, Table 1 indicates that 22.3%, 60.9% and 39.0% of the total excretion of chondroitin sulfate B decrease in Cases 1, 2 and 3 on the third or fourth day compared with those before the plasma infusion. The data in 
